The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Zabier, Tabassam
    Sales Director born in October 1978
    Individual (20 offsprings)
    Officer
    2019-02-18 ~ now
    OF - Director → CIF 0
    Mr Tabassam Zabier
    Born in October 1978
    Individual (20 offsprings)
    Person with significant control
    2019-02-18 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

ZABIER PHARMA-CONSULTING LTD

Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Property, Plant & Equipment
3,457 GBP2024-02-28
4,067 GBP2023-02-28
Fixed Assets
3,457 GBP2024-02-28
4,067 GBP2023-02-28
Debtors
2,466,941 GBP2024-02-28
2,656,557 GBP2023-02-28
Cash at bank and in hand
17,366 GBP2024-02-28
85,501 GBP2023-02-28
Current Assets
2,484,307 GBP2024-02-28
2,742,058 GBP2023-02-28
Creditors
-59,704 GBP2024-02-28
-150,954 GBP2023-02-28
Net Current Assets/Liabilities
2,424,603 GBP2024-02-28
2,591,104 GBP2023-02-28
Total Assets Less Current Liabilities
2,428,060 GBP2024-02-28
2,595,171 GBP2023-02-28
Net Assets/Liabilities
2,428,060 GBP2024-02-28
2,595,171 GBP2023-02-28
Equity
Called up share capital
100 GBP2024-02-28
100 GBP2023-02-28
Retained earnings (accumulated losses)
2,427,960 GBP2024-02-28
2,595,071 GBP2023-02-28
Average Number of Employees
22023-03-01 ~ 2024-02-28
22022-03-01 ~ 2023-02-28
Property, Plant & Equipment - Gross Cost
5,629 GBP2024-02-28
5,629 GBP2023-02-28
Property, Plant & Equipment - Accumulated Depreciation & Impairment
2,172 GBP2024-02-28
1,562 GBP2023-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
610 GBP2023-03-01 ~ 2024-02-28

  • ZABIER PHARMA-CONSULTING LTD
    Info
    Registered number 11832545
    10 St. Marys Place, C/o Jackson Lee Accountants, Bury BL9 0DZ
    Private Limited Company incorporated on 2019-02-18 (6 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-17
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.